Take part in a year-long research project under the guidance of experts. Finetune your skills and enhance your knowledge in a leading certified EUSP host centre abroad.
About the scholarship
Every year, the EUSP Board contacts host centres about research projects that future scholars can undertake. Alternatively, applicants can also submit their own project proposals.
As of 2026 one-year scholarships can only be performed in Certified EUSP Host Centres. Host centres that are not certified can apply via de website of the European Board of Urology.
How to apply
When you apply online, please include the following documents:
About the scholarship grant
A maximum grant of €30,000 is allotted to each accepted project proposal. The grant will be transferred in 3 parts:
Please include a well-documented budget proposal with your application. The budget proposal should be a complete financial overview which includes estimated costs of food expenses, accommodation, travel expenses for 1 round trip, and limited reimbursements for continuing expenses in your home country after the scholarship (e.g. continuation of insurances and other costs) wherein documentation can be presented.
The EUSP grant is meant to finance the above-mentioned costs made only by the applicant, and not by accompanying persons.
EAU is clinically focused. Proposals must:
Address a clearly defined urological disease or clinical problem
Have direct potential to improve diagnosis, treatment, outcomes, or guideline-based practice
Show significance for European urology practice or patient populations
Predictor: Clear, high-impact clinical relevance is essential.
EAU strongly values studies that:
Involve multiple European centers
Increase generalizability and sample size
Build collaborative networks among urologists
Leverage EAU Section Groups (ESU, ESUT, ESGE, ESOU, etc.)
Predictor: Multi-institution collaborations significantly increase competitiveness.
Successful EAU applications demonstrate:
Well-defined research question and hypothesis
Specific, measurable primary and secondary endpoints
Adequate statistical plan, power analysis, and study feasibility
Ethical approval and realistic patient recruitment strategy
Achievable timeline (often 1–2 years)
Clear risk mitigation
Predictor: Rigor + feasibility = high reviewer confidence.
EAU favors proposals that are:
Innovative (e.g., new biomarkers, imaging modalities, surgical navigation, AI-assisted tools)
Translational (lab → clinic)
Cutting-edge (robotics, minimally invasive techniques, computational modeling)
Aligned with precision urology trends
Predictor: Innovation that is clinically meaningful.
Not always required, but highly advantageous.
Competitive applications usually include:
Pilot data supporting feasibility
Early mechanistic insights (for translational studies)
Retrospective data supporting rationale
Technical proof-of-concept for devices or imaging tools
Predictor: Preliminary data strengthens credibility.
EAU prioritizes research that:
Can change clinical pathways
Contributes to EAU Guidelines
Enhances treatment stratification or personalized care
Improves patient-reported outcomes or quality of life
Predictor: Clear potential to affect guidelines or standard-of-care practice.
Reviewers look for:
Relevant expertise (urology subspecialty experience)
Multidisciplinary involvement (radiology, oncology, pathology, AI specialists, health economists)
Early-career investigators paired with senior mentors
Demonstrated capacity to deliver the proposed project
Infrastructure (clinical recruitment sites, labs, registries)
Predictor: Proven ability to execute and collaborate.
EAU grants are competitive and typically modest. Strong proposals include:
Realistic and efficient budgets
Clear justification for personnel, data collection, consumables, imaging, biostatistics, travel for collaboration
Alignment of budget to aims
No inflated or unnecessary costs
Predictor: Lean, well-aligned budgets improve credibility.
Proposals scoring highly often incorporate:
PROMs (patient-reported outcome measures)
Quality-of-life assessment
Satisfaction, recovery time, functional outcomes
Minimally invasive alternatives with patient benefit
Predictor: Clear patient benefit strengthens impact.
| Pitfall | Why It Hurts |
|---|---|
| Lack of specific clinical relevance to urology | Mission mismatch |
| Overly ambitious multi-aim project for limited budget | Feasibility issues |
| Weak methodology or missing statistics | Low scientific rigor |
| Limited collaboration or single-center design | Lower priority |
| No preliminary data for high-risk ideas | Too speculative |
| Unclear rationale or endpoint | Reviewers struggle to assess value |
| Budget poorly justified | Decreases confidence |
| Unclear impact on clinical practice | Low perceived value |
You are eligible to apply if you are:
Sponsor Institute/Organizations: European Association of Urology
Sponsor Type: Corporate/Non-Profit
Address: PO Box 30016 NL-6803 AA ARNHEM
Affiliation Disclaimer: Trialect operates independently and is not affiliated with, endorsed by, or supported by any sponsors or organizations posting on the GrantsBoard platform. As an independent aggregator of publicly available funding opportunities, Trialect provides equal access to information for all users without endorsing any specific funding source, content, organization, or sponsor. Trialect assumes no responsibility for the content posted by sponsors or third parties.
Subscription Disclaimer: Upon logging into Trialect, you may choose to SUBSCRIBE to GrantsBoard for timely notifications of funding opportunities and to access exclusive benefits, such as priority alerts, reminders, personalized recommendations, and additional application support. However, users are advised to contact sponsors directly for any questions and are not required to subscribe to engage with funding opportunities.
Content Ownership and Copyright Disclaimer: Trialect respects the intellectual property rights of all organizations and individuals. All content posted on GrantsBoard is provided solely for informational purposes and remains the property of the original owners. Trialect does not claim ownership of, nor does it have any proprietary interest in, content provided by third-party sponsors. Users are encouraged to verify content and ownership directly with the posting sponsor.
Fair Use Disclaimer: The information and content available on GrantsBoard are compiled from publicly accessible sources in alignment with fair use principles under U.S. copyright law. Trialect serves as an aggregator of this content, offering it to users in good faith and with the understanding that it is available for public dissemination. Any organization or individual who believes their intellectual property rights have been violated is encouraged to contact us for prompt resolution.
Third-Party Posting Responsibility Disclaimer: Trialect is a neutral platform that allows third-party sponsors to post funding opportunities for informational purposes only. Sponsors are solely responsible for ensuring that their postings comply with copyright, trademark, and other intellectual property laws. Trialect assumes no liability for any copyright or intellectual property infringements in third-party content and will take appropriate action to address any substantiated claims.
Accuracy and Verification Disclaimer: Trialect makes no warranties regarding the accuracy, completeness, or reliability of the information provided by sponsors. Users are advised to verify the details of any funding opportunity directly with the sponsor before taking action. Trialect cannot be held liable for any discrepancies, omissions, or inaccuracies in third-party postings.
Notice and Takedown Policy: Trialect is committed to upholding copyright law and protecting the rights of intellectual property owners. If you believe that content on GrantsBoard infringes your copyright or intellectual property rights, please contact us with detailed information about the claim. Upon receipt of a valid notice, Trialect will promptly investigate and, where appropriate, remove or disable access to the infringing content.
Jan 01, 2026
Jan 01, 2026
$34,800
Affiliation: European Association of Urology
Address: PO Box 30016 NL-6803 AA ARNHEM
Website URL: https://uroweb.org/education/scholarships/1-year-scholarship
Disclaimer:It is mandatory that all applicants carry workplace liability insurance, e.g., https://www.protrip-world-liability.com (Erasmus students use this package and typically costs around 5 € per month - please check) in addition to health insurance when you join any of the onsite Trialect partnered fellowships.